Vanguard Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $50.6M | Buy |
8,225,371
+342,856
| +4% | +$2.49M | ﹤0.01% | 2157 |
|
|
2025
Q3 | $57M | Sell |
7,882,515
-1,374,978
| -15% | -$8.16M | ﹤0.01% | 2096 |
|
|
2025
Q2 | $49.2M | Sell |
9,257,493
-1,410,262
| -13% | -$8.33M | ﹤0.01% | 2129 |
|
|
2025
Q1 | $94.6M | Buy |
10,667,755
+76,712
| +0.7% | +$921K | ﹤0.01% | 1823 |
|
|
2024
Q4 | $145M | Buy |
10,591,043
+279,379
| +3% | +$5.16M | ﹤0.01% | 1687 |
|
|
2024
Q3 | $282M | Buy |
10,311,664
+246,993
| +2% | +$6.69M | 0.01% | 1354 |
|
|
2024
Q2 | $246M | Buy |
10,064,671
+28,963
| +0.3% | +$635K | ﹤0.01% | 1380 |
|
|
2024
Q1 | $214M | Buy |
10,035,708
+81,475
| +0.8% | +$1.75M | ﹤0.01% | 1473 |
|
|
2023
Q4 | $191M | Buy |
9,954,233
+789,496
| +9% | +$13.7M | ﹤0.01% | 1531 |
|
|
2023
Q3 | $147M | Buy |
9,164,737
+12,390
| +0.1% | +$236K | ﹤0.01% | 1593 |
|
|
2023
Q2 | $212M | Sell |
9,152,347
-146,067
| -2% | -$3.19M | 0.01% | 1440 |
|
|
2023
Q1 | $216M | Sell |
9,298,414
-13,347
| -0.1% | -$271K | 0.01% | 1411 |
|
|
2022
Q4 | $135M | Buy |
9,311,761
+183,377
| +2% | +$3.42M | ﹤0.01% | 1635 |
|
|
2022
Q3 | $174M | Buy |
9,128,384
+121,704
| +1% | +$2.79M | 0.01% | 1464 |
|
|
2022
Q2 | $164M | Buy |
9,006,680
+30,087
| +0.3% | +$625K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $226M | Sell |
8,976,593
-172,928
| -2% | -$4.43M | 0.01% | 1478 |
|
|
2021
Q4 | $253M | Buy |
9,149,521
+116,324
| +1% | +$3.37M | 0.01% | 1462 |
|
|
2021
Q3 | $292M | Buy |
9,033,197
+82,377
| +0.9% | +$2.74M | 0.01% | 1343 |
|
|
2021
Q2 | $274M | Buy |
8,950,820
+326,155
| +4% | +$9.42M | 0.01% | 1427 |
|
|
2021
Q1 | $263M | Buy |
8,624,665
+327,801
| +4% | +$9.3M | 0.01% | 1419 |
|
|
2020
Q4 | $164M | Buy |
8,296,864
+298,846
| +4% | +$4.83M | ﹤0.01% | 1573 |
|
|
2020
Q3 | $104M | Sell |
7,998,018
-248,394
| -3% | -$3.14M | ﹤0.01% | 1673 |
|
|
2020
Q2 | $93.5M | Sell |
8,246,412
-119,035
| -1% | -$1.69M | ﹤0.01% | 1713 |
|
|
2020
Q1 | $120M | Buy |
8,365,447
+44,873
| +0.5% | +$948K | 0.01% | 1425 |
|
|
2019
Q4 | $227M | Sell |
8,320,574
-329,677
| -4% | -$9.07M | 0.01% | 1319 |
|
|
2019
Q3 | $248M | Buy |
8,650,251
+326,482
| +4% | +$9.51M | 0.01% | 1204 |
|
|
2019
Q2 | $231M | Sell |
8,323,769
-214,508
| -3% | -$6.06M | 0.01% | 1271 |
|
|
2019
Q1 | $283M | Sell |
8,538,277
-654,438
| -7% | -$19.9M | 0.01% | 1126 |
|
|
2018
Q4 | $267M | Buy |
9,192,715
+535,782
| +6% | +$19.3M | 0.01% | 1059 |
|
|
2018
Q3 | $398M | Buy |
8,656,933
+365,697
| +4% | +$16.3M | 0.02% | 918 |
|
|
2018
Q2 | $310M | Buy |
8,291,236
+516,568
| +7% | +$17.4M | 0.01% | 1061 |
|
|
2018
Q1 | $230M | Buy |
7,774,668
+550,366
| +8% | +$18.6M | 0.01% | 1197 |
|
|
2017
Q4 | $248M | Buy |
7,224,302
+896,790
| +14% | +$30.3M | 0.01% | 1157 |
|
|
2017
Q3 | $229M | Buy |
6,327,512
+19,774
| +0.3% | +$564K | 0.01% | 1174 |
|
|
2017
Q2 | $163M | Buy |
6,307,738
+56,708
| +0.9% | +$1.2M | 0.01% | 1361 |
|
|
2017
Q1 | $120M | Buy |
6,251,030
+897,287
| +17% | +$15.9M | 0.01% | 1555 |
|
|
2016
Q4 | $89.2M | Buy |
5,353,743
+158,531
| +3% | +$2.87M | 0.01% | 1698 |
|
|
2016
Q3 | $107M | Sell |
5,195,212
-1,454
| -0% | -$36.9K | 0.01% | 1518 |
|
|
2016
Q2 | $159M | Buy |
5,196,666
+121,681
| +2% | +$4.23M | 0.01% | 1203 |
|
|
2016
Q1 | $190M | Buy |
5,074,985
+221,336
| +5% | +$8.34M | 0.01% | 1056 |
|
|
2015
Q4 | $209M | Buy |
4,853,649
+173,406
| +4% | +$7.33M | 0.01% | 972 |
|
|
2015
Q3 | $175M | Sell |
4,680,243
-7,432
| -0.2% | -$264K | 0.01% | 1077 |
|
|
2015
Q2 | $159M | Sell |
4,687,675
-60,354
| -1% | -$2.05M | 0.01% | 1217 |
|
|
2015
Q1 | $168M | Sell |
4,748,029
-4,607
| -0.1% | -$165K | 0.01% | 1134 |
|
|
2014
Q4 | $162M | Sell |
4,752,636
-45,831
| -1% | -$1.63M | 0.01% | 1101 |
|
|
2014
Q3 | $185M | Sell |
4,798,467
-252,196
| -5% | -$9.41M | 0.01% | 980 |
|
|
2014
Q2 | $197M | Buy |
5,050,663
+180,073
| +4% | +$6.7M | 0.02% | 968 |
|
|
2014
Q1 | $167M | Sell |
4,870,590
-14,801
| -0.3% | -$459K | 0.01% | 1031 |
|
|
2013
Q4 | $102M | Buy |
4,885,391
+45,402
| +0.9% | +$1.15M | 0.01% | 1301 |
|
|
2013
Q3 | $114M | Buy |
4,839,989
+439,892
| +10% | +$12.5M | 0.01% | 1157 |
|
|
2013
Q2 | $118M | Buy |
+4,400,097
| New | +$128M | 0.01% | 1057 |
|
Other funds holding MYGN
GCM
Vanguard Group's MYGN Position: Q4 2025 in Review
Vanguard Group increased its Myriad Genetics (MYGN) stake by 4.3% in Q4 2025, buying an estimated $2.49M and bringing the position to 8,225,371 shares worth $50.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.
Vanguard Group first reported a position in MYGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $398M in Q3 2018. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.
- Vanguard Group held 8,225,371 shares of Myriad Genetics worth $50.6M as of Q4 2025.
- Vanguard Group bought 342,856 Myriad Genetics shares in Q4 2025, an estimated $2.49M.
- Myriad Genetics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2157 holding.
- Vanguard Group first reported a position in Myriad Genetics in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Myriad Genetics position peaked at $398M in Q3 2018.
- 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.